Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-072999
Filing Date
2011-08-04
Accepted
2011-08-04 17:05:50
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q g27643e10vq.htm 10-Q 320609
2 EX-10.2 g27643exv10w2.htm EX-10.2 48674
3 EX-31.1 g27643exv31w1.htm EX-31.1 8102
4 EX-31.2 g27643exv31w2.htm EX-31.2 8366
5 EX-32.1 g27643exv32w1.htm EX-32.1 3055
6 EX-32.2 g27643exv32w2.htm EX-32.2 3092
12 GRAPHIC g27643g2764300.gif GRAPHIC 3418
  Complete submission text file 0000950123-11-072999.txt   1593576

Data Files

Seq Description Document Type Size
7 EX-101 INSTANCE DOCUMENT bcrx-20110630.xml EX-101.INS 181334
8 EX-101 SCHEMA DOCUMENT bcrx-20110630.xsd EX-101.SCH 8697
9 EX-101 CALCULATION LINKBASE DOCUMENT bcrx-20110630_cal.xml EX-101.CAL 32694
10 EX-101 LABELS LINKBASE DOCUMENT bcrx-20110630_lab.xml EX-101.LAB 100212
11 EX-101 PRESENTATION LINKBASE DOCUMENT bcrx-20110630_pre.xml EX-101.PRE 60295
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 111011221
SIC: 2836 Biological Products, (No Diagnostic Substances)